Singapore markets close in 3 hours 30 minutes
Straits Times Index
3,301.78 +9.09 (+0.28%) Nikkei
38,277.56 +3.51 (+0.01%) Hang Seng
18,194.37 +431.34 (+2.43%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,264.97 -2,710.46 (-4.52%) CMC Crypto 200
1,259.67 -79.40 (-5.93%)
Swedish Orphan Biovitrum AB (publ) (BIOVF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 01:26PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.80B |
| Enterprise value | 10.49B |
| Trailing P/E | 39.60 |
| Forward P/E | 24.75 |
| PEG ratio (5-yr expected) | 1.22 |
| Price/sales (ttm) | 3.61 |
| Price/book (mrq) | 2.37 |
| Enterprise value/revenue | 0.45 |
| Enterprise value/EBITDA | 1.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.26 |
| 52-week change 3 | -3.05% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 27.79 |
| 52-week low 3 | 18.35 |
| 50-day moving average 3 | 25.17 |
| 200-day moving average 3 | 22.79 |
Share statistics
| Avg vol (3-month) 3 | 88 |
| Avg vol (10-day) 3 | 300 |
| Shares outstanding 5 | 339.87M |
| Implied shares outstanding 6 | 400.5M |
| Float 8 | 198.7M |
| % held by insiders 1 | 10.08% |
| % held by institutions 1 | 73.89% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in SEK.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 9.26% |
| Operating margin (ttm) | 23.47% |
Management effectiveness
| Return on assets (ttm) | 4.51% |
| Return on equity (ttm) | 6.72% |
Income statement
| Revenue (ttm) | 23.14B |
| Revenue per share (ttm) | 69.38 |
| Quarterly revenue growth (yoy) | 19.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 7.77B |
| Net income avi to common (ttm) | 2.14B |
| Diluted EPS (ttm) | 0.58 |
| Quarterly earnings growth (yoy) | -25.00% |
Balance sheet
| Total cash (mrq) | 527M |
| Total cash per share (mrq) | 1.55 |
| Total debt (mrq) | 19.22B |
| Total debt/equity (mrq) | 53.54% |
| Current ratio (mrq) | 0.71 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 4.74B |
| Levered free cash flow (ttm) | 2.69B |
© 2024 Yahoo. All rights reserved.